Scientists hunt for hidden cancer clues in Patients' surgical drain fluid
NCT ID NCT05338060
Summary
This study aimed to find biological markers that could help predict which stomach or esophageal cancer patients might respond well to immunotherapy. Researchers collected fluid from surgical drains and blood samples from 10 patients who had cancer-removal surgery. They analyzed these samples in the lab, looking for signals that might indicate if the cancer is likely to return early or stay away.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.